慢病毒 腺相关病毒

About Us

OBiO Technology (Shanghai) Corp., Ltd. is a biopharmaceutical CDMO/CMO company founded in 2013 which currently has more than 380 employees, over a quarter of whom are educated to PhD and M.Sc level. In 2016, OBiO built its gene therapy manufacturing platform meeting regulatory requirements in China, Europe and the United States. The GMP platform offers holistic CDMO services across plasmid, adeno-associated virus, lentivirus, adenovirus, oncolytic viruses, and cell therapy products for scientists, research facilities, medical institutions, and pharmaceutical companies. In 2020, OBiO initiated construction of a 80,000sqm OBiO Intelli-M GMP manufacturing site in Shanghai to satisfy explosive global demand for gene therapy products. OBiO strives to become the leading gene therapy CDMO and a trustworthy partner for global biopharmaceuticals and biotech companies.

CDMO Services

In 2016, OBiO built its gene therapy manufacturing platform that meets the regulatory requirements in China, Europe and the United States. Our GMP platform offers holistic CDMO services across plasmid, adeno-associated virus, lentivirus, adenovirus, oncolytic viruses, and cell therapy products for scientists, research facilities, medical institutions, and pharmaceutical companies. Starting from 2020, OBiO has initiated the construction of the 80,000m2 OBiO Intelli-M GMP manufacturing site in Shanghai to satisfy the explosively growing global demand on gene therapy products, striving to become the leading gene therapy CDMO and the trustful partner for global biopharmaceuticals and biotech companies.

CDMO Services

2019-2021 OBiO Technology (Shanghai) Corp., Ltd. All rights reserved. 备案号:
金牛网155755-金牛网112238-678333金牛网论坛-42923acom金牛版-金牛网678333com香港 678333金牛网论坛-金牛网论坛155755开奖记录-金牛网155755cow www717888com黑码堂-565888黑码堂-黑码堂高手论坛06633-黑码堂心论坛565888 2021澳门合彩开彩结果-澳门118开奖115516-澳门118开奖118186 pc加拿大28在线预测网站-加拿大28算法90胜率-加拿大28百分百中算法 2021香港六和全年资料-香港六码中特-香港合彩历史中奖记录